Benzinga's Top Pre-Market Gainers

Exelixis

added 10.63% to $7.08 in the pre-market session. Exelixis reported that the US Food and Drug Administration (FDA) has granted priority review for cabozantinib in medullary thyroid cancer. Jacobs Engineering Group

soared 6.19% to $41.89 in the pre-market trading. Jacobs Engineering is expected to report its third-quarter earnings after the closing bell. Sprint Nextel

surged 4.64% to $4.51 in the pre-market session. Sprint Nextel's trailing-twelve-month revenue is $34.63 billion. Fluor

moved up 4.43% to $52.82 in the pre-market session. Fluor's PEG ratio is 1.23.